UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 27, 2025

INNOVATIVE EYEWEAR, INC.

(Exact name of registrant as specified in its charter)

Florida		001-41392		85-0734861
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

11900 Biscayne Blvd., Suite 630

North Miami, Florida

33181

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (786) 785-5178

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.00001 per share	LUCY	The Nasdaq Stock Market LLC
Warrants to purchase Common Stock	LUCYW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.08

Shareholder Director Nominations.

On June 27, 2025, the Board of Directors of Innovative Eyewear, Inc. (the “Company”) determined that Tuesday, August 26, 2025, shall be the scheduled date of the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”). The time and meeting website information for the 2025 Annual Meeting will be set forth in the Company’s proxy statement for the 2025 Annual Meeting, which will be filed with the Securities and Exchange Commission (the “SEC”) prior to the 2025 Annual Meeting.

Because the date of the 2025 Annual Meeting is scheduled more than 30 days after the anniversary of the Company’s 2024 annual meeting of stockholders, the Company is providing in this Current Report on Form 8-K the due dates for submissions of stockholder director nominations.

A director nomination (including nominations pursuant to Rule 14a-19 under the Exchange Act) outside of Rule 14a-8 under the Exchange Act and pursuant to the Company’s Amended and Restated Bylaws (the “Bylaws”) must have been received by the Company by July 10, 2025.

Stockholder director nominations must comply with all applicable requirements set forth in the rules and regulations of the SEC, the Exchange Act, and the Bylaws.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 30, 2025

	INNOVATIVE EYEWEAR, INC.

	By:	/s/ Harrison Gross
	Name:	Harrison Gross
	Title:	Chief Executive Officer

Innovative Eyewear Inc 8-K